Menopause, Pelvic Floor Changes, and How EMS Therapy Helps Women Over 40

Menopause, Pelvic Floor Changes, and How EMS Therapy Helps Women Over 40

Menopause is a natural biological transition that every woman experiences — but its effects on the pelvic floor are rarely discussed with the frankness they deserve. The hormonal changes of menopause, particularly the dramatic decline in oestrogen, have profound effects on pelvic floor tissue quality, muscle strength, and function. For many women, menopause marks the point at which previously manageable pelvic floor symptoms — or symptoms they were not even aware of — become significantly more pronounced.

The good news is that pelvic floor decline associated with menopause is not inevitable or irreversible. EMS pelvic floor therapy, delivered through dedicated devices like the Riorna EMSlim Pelvic Floor Chair, offers women over 40 a clinically supported, non-invasive way to maintain and rebuild pelvic floor strength through and beyond the menopausal transition.

What Menopause Does to the Pelvic Floor

To understand why EMS pelvic floor therapy is particularly valuable for women over 40, it is important to understand the specific ways in which menopause affects pelvic floor health.

The Role of Oestrogen in Pelvic Floor Health

Oestrogen plays a critical role in maintaining the health and function of pelvic floor tissue. It supports the strength, elasticity, and thickness of the vaginal walls and urethral lining, maintains the quality and responsiveness of the pelvic floor muscles and their supporting connective tissues, and supports the health of the nerve supply to the pelvic floor — which is essential for the reflex contractions that prevent urinary leakage.

During the perimenopause and menopause, oestrogen levels decline dramatically — typically falling by 80–90% from their premenopausal levels. This decline has direct consequences for pelvic floor health that unfold progressively over the years following menopause.

Genitourinary Syndrome of Menopause

The collection of pelvic floor and urogenital changes associated with oestrogen decline is now recognised clinically as the Genitourinary Syndrome of Menopause (GSM). GSM encompasses a range of symptoms including vaginal dryness and atrophy, urethral thinning and increased susceptibility to urinary tract infections, progressive pelvic floor muscle weakness, worsening urinary incontinence, pelvic organ prolapse, and reduced sexual sensation and satisfaction.

GSM affects the majority of postmenopausal women to some degree, yet it remains significantly undertreated — partly because many women assume these symptoms are an inevitable and untreatable part of ageing, and partly because the symptoms are often embarrassing to discuss.

Accelerated Muscle Atrophy

The decline in oestrogen at menopause accelerates the age-related loss of muscle mass (sarcopenia) throughout the body — including in the pelvic floor muscles. Postmenopausal women lose pelvic floor muscle mass and strength at a faster rate than premenopausal women of the same age, contributing to the progressive worsening of pelvic floor symptoms that many women experience in the years following menopause.

This accelerated muscle atrophy is compounded by the fact that many postmenopausal women are less physically active than they were in earlier decades, further reducing the natural stimulus for muscle maintenance.

Common Pelvic Floor Symptoms in Women Over 40

The pelvic floor symptoms that women over 40 most commonly experience as a result of menopausal changes include urinary leakage during coughing, sneezing, laughing, or exercise (stress urinary incontinence), sudden urgent need to urinate with difficulty deferring (urge urinary incontinence), increased frequency of urination during the day and night, recurrent urinary tract infections, a sensation of heaviness or pressure in the pelvis (suggesting pelvic organ prolapse), vaginal dryness and discomfort during intercourse, and reduced sexual sensation and satisfaction.

Many women experience several of these symptoms simultaneously, and their impact on quality of life — including sleep quality, social confidence, physical activity, and intimate relationships — can be substantial.

Why Conventional Approaches Often Fall Short for Menopausal Women

The standard first-line recommendation for pelvic floor weakness — Kegel exercises — faces particular challenges in postmenopausal women. The oestrogen-depleted pelvic floor muscles are less responsive to voluntary exercise stimuli, meaning that the hypertrophy response to Kegel exercises is reduced compared to premenopausal women. Additionally, the nerve supply changes associated with oestrogen decline can make it harder for postmenopausal women to correctly identify and voluntarily contract their pelvic floor muscles.

The result is that many postmenopausal women find Kegel exercises less effective than they were in earlier life — and may become discouraged and abandon them before achieving meaningful results.

How EMS Pelvic Floor Therapy Addresses Menopausal Pelvic Floor Changes

EMS pelvic floor therapy overcomes the specific challenges that menopause creates for conventional pelvic floor exercise in several important ways.

Bypassing Voluntary Activation Limitations

Because EMS therapy stimulates the pelvic floor muscles directly through electromagnetic fields — bypassing the need for voluntary muscle activation — it is not affected by the reduced ability to voluntarily identify and contract the pelvic floor muscles that many postmenopausal women experience. The machine delivers the full therapeutic stimulus regardless of the client's ability to voluntarily engage the muscles.

Supramaximal Stimulus Overcomes Reduced Muscle Responsiveness

The supramaximal contractions produced by HIFEM technology create a muscle hypertrophy stimulus that is far more powerful than any voluntary exercise can achieve. Even in the oestrogen-depleted environment of menopause, where muscle responsiveness to exercise is reduced, the intensity of the EMS stimulus is sufficient to trigger meaningful muscle hypertrophy and strength gains in the pelvic floor.

Collagen Stimulation Through RF Technology

For women using RF-enabled devices, the radiofrequency component of treatment can help address the tissue quality changes associated with oestrogen decline by stimulating collagen and elastin production in the pelvic floor and vaginal tissue. This can help improve vaginal tone and tissue quality, complementing the muscle-strengthening effects of the HIFEM component.

What Results Can Women Over 40 Expect?

Women over 40 who undergo a standard course of EMS pelvic floor therapy can expect meaningful improvements in urinary control and continence, reduced urgency and frequency of urination, improved pelvic floor muscle strength and tone, and in many cases, improvements in sexual sensation and satisfaction. Most women begin to notice improvements within the first 2–3 sessions, with optimal results developing over the 4–8 weeks following the completion of a standard course of 6–8 sessions.

Results may develop slightly more slowly in postmenopausal women than in younger women, reflecting the reduced hormonal environment. However, the fundamental mechanisms of muscle hypertrophy operate at all ages, and meaningful improvements are achievable for the vast majority of women who undergo treatment.

For a full overview of safety considerations, see our EMSlim Side Effects and Safety Guide.

Combining EMS Pelvic Therapy with Body Sculpting for Women Over 40

Many women over 40 are simultaneously dealing with pelvic floor changes and body composition changes associated with menopause — including increased abdominal fat, loss of muscle tone, and skin laxity. Combining EMS pelvic floor therapy with standard EMS body sculpting using the Riorna EMSlim body sculpting range can provide a comprehensive approach to the physical changes of menopause — addressing pelvic floor health, muscle tone, fat reduction, and skin tightening simultaneously.

Conclusion

Menopause accelerates pelvic floor decline in ways that conventional exercise often cannot adequately address — but this decline is not inevitable or irreversible. EMS pelvic floor therapy, delivered through the Riorna EMSlim Pelvic Floor Chair, provides women over 40 with a powerful, non-invasive, and clinically supported tool for maintaining and rebuilding pelvic floor strength through and beyond the menopausal transition.

For women experiencing pelvic floor symptoms related to menopause, EMS therapy represents one of the most effective and accessible treatment options currently available — and one that can meaningfully improve quality of life, bladder control, and sexual wellness in the years following menopause.

👉 Explore the Riorna EMSlim Pelvic Floor Chair and reclaim your pelvic health →

Back to blog